Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2006; 12(1): 94-98
Published online Jan 7, 2006. doi: 10.3748/wjg.v12.i1.94
Table 1 Characteristics of the patients and levels of L1 expression n(%)
VariablePatientsL1-positive tumors
Total635 (7.9)
Male32(50.8)4 (12.5)
Female31(49.2)1 (3.2)
WHO classification of neuroendocrine pancreatic tumour
Well-differentiated neuroendocrine tumour (grade 1a)50(79.4)1 (2.0)
Well-differentiated neuroendocrine carcinoma (grade 1b)4(6.3)0
Poorly-differentiated neuroendocrine carcinoma (grade 2)9(14.3)4 (44.4)
Hormone production
Yes11(17.5)0
No52(82.5)5 (9.6)
Multiple endocrine neoplasia (MEN)-I
MEN-I6(9.5)0
No MEN-I57(90.5)5 (8.8)